Laidlaw & Co. Initiates Coverage On BiomX with Buy Rating, Announces Price Target of $2.5
Portfolio Pulse from Benzinga Newsdesk
Laidlaw & Co. has initiated coverage on BiomX (AMEX:PHGE) with a Buy rating and set a price target of $2.5.
May 28, 2024 | 3:36 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Laidlaw & Co. has initiated coverage on BiomX with a Buy rating and set a price target of $2.5.
The initiation of coverage with a Buy rating and a specific price target of $2.5 by Laidlaw & Co. is likely to positively impact BiomX's stock price in the short term. Analyst ratings and price targets are significant indicators for investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100